HonCode

Go Back   HER2 Support Group Forums > her2group
Register Gallery FAQ Members List Calendar Today's Posts

 
 
Thread Tools Display Modes
Prev Previous Post   Next Post Next
Old 01-12-2007, 06:55 AM   #1
Kimberly Lewis
Senior Member
 
Kimberly Lewis's Avatar
 
Join Date: Nov 2005
Location: Hilton Head Island, SC
Posts: 279
Oncotype DX now covered by UHC..

<table id="article_tbl" align="left" border="0" cellpadding="0" cellspacing="0" width="970"><tbody><tr><td class="left_col" width="600"> UnitedHealth to cover cancer-recurrence tests

Minneapolis/St. Paul Business Journal - 12:54 PM CST Wednesday
by Carissa Wyant
Staff Writer


<!-- Article Tools --> United Healthcare Insurance Co. said Wednesday that it will offer coverage of a test for breast cancer recurrence.

Genomic Health Inc., which makes gene-based cancer tests, entered into an agreement with the affiliate of Minnetonka-based health insurer UnitedHealth Group. The new deal establishes coverage across all of UnitedHealthcare's plans for women with early-stage breast cancer. Coverage will become effective for claims for services performed on or after Jan. 3.

<table id="article_island_ad" align="left" border="0" cellpadding="0" cellspacing="0"> <tbody><tr> <td> <!-- 336 x 280 Ad --> <script language="JavaScript1.1" type="text/javascript" src="http://dc.bizjournals.com/js.ng/site=bizj&market=twincities&is_story=1&affiliate=t wincities&pos=c1&svs=health_care__physician_practi ces&transactionid=1168609173.253448.2179&tile=3977 2083815?"> </script><iframe src="http://view.atdmt.com/HBO/iview/bzjrmlib0110000003hbo/direct/01?click=" marginheight="0" marginwidth="0" topmargin="0" leftmargin="0" allowtransparency="true" frameborder="0" height="250" scrolling="no" width="300"> &lt;a href="http://clk.atdmt.com/HBO/go/bzjrmlib0110000003hbo/direct/01/" target="_blank"&gt;&lt;img src="http://view.atdmt.com/HBO/view/bzjrmlib0110000003hbo/direct/01/"/&gt;&lt;/a&gt;&lt;noscript&gt;&lt;a href="http://clk.atdmt.com/HBO/go/bzjrmlib0110000003hbo/direct/01/" target="_blank"&gt;&lt;img border="0" src="http://view.atdmt.com/HBO/view/bzjrmlib0110000003hbo/direct/01/" /&gt;&lt;/a&gt;&lt;/noscript&gt;</iframe> </td></tr></tbody></table> Oncotype DX quantifies the likelihood of breast cancer recurrence and predicts the likelihood of chemotherapy benefit for a large portion of early-stage breast cancer patients, Genomic Health said.

Contracts in place for Oncotype DX cover over 98 million people.

cwyant@bizjournals.com | (612) 288-2108



<!-- Send us your comments & More Latest News Buttons --> Contact the Editor Need Assistance? More Latest News

Subscribe or renew online

<!-- Extra Special --> Extra

What top jobs pay

How salaries for 20 key professions vary across the nation


<table id="related_tbl" align="left" border="0" cellpadding="0" cellspacing="0"> <tbody><tr> <td class="left_related_col" width="280">
</td><td class="right_related_col">
</td></tr><tr><td colspan="2">
</td></tr></tbody></table>
</td><td class="right_col">
</td></tr></tbody></table>
__________________
Kim

Diagnosed 7/05
Stage 3a er+(45%) pr+(68%) Her2+ (40%)
3.8 cm + .8cm multi focal - pleomorphic lobular tumors
high grade DCIS
7/20 nodes

BRCA 2
positive as of 5/07
surgeries: double mastectomy, hysterectomy (LAVH)
A/C,Herceptin for 1 year completed 11/06
femara


Kimberly Lewis is offline   Reply With Quote
 


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump


All times are GMT -7. The time now is 05:25 AM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021
free webpage hit counter